Qi Yi Luo
Director/Board Member bij MICROPORT SCIENTIFIC CORPORATION
Vermogen: 7 M $ op 29-02-2024
Profiel
Momenteel is Qi Yi Luo niet-uitvoerend voorzitter van MicroPort CardioFlow Medtech Corp. en Chief Technology Officer van MicroPort Scientific Corp., en voorzitter van Shanghai MicroPort CardioFlow Medtech Co., Ltd. (een dochteronderneming van MicroPort Scientific Corp.). (een dochteronderneming van MicroPort Scientific Corp.). De heer Luo is tevens lid van de raad van bestuur van Shanghai MicroPort EP MedTech Co, Ltd. (een dochteronderneming van MicroPort Scientific Corp.). De heer Luo is afgestudeerd aan de Queen's University, heeft een undergraduate degree van de Yunnan Technology & Business University en is gepromoveerd aan de University of Shanghai Science & Technology.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
30-08-2023 | 6 503 897 ( 0.35% ) | 6 M $ | 29-02-2024 | |
30-06-2022 | 6 413 144 ( 0.27% ) | 1 M $ | 29-02-2024 |
Actieve functies van Qi Yi Luo
Bedrijven | Functie | Begin |
---|---|---|
MICROPORT SCIENTIFIC CORPORATION | Director/Board Member | 30-08-2023 |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Director/Board Member | 28-04-2020 |
Eerdere bekende functies van Qi Yi Luo
Bedrijven | Functie | Einde |
---|---|---|
SHANGHAI MICROPORT EP MEDTECH CO., LTD. | Director/Board Member | 15-09-2023 |
MICROPORT CARDIOFLOW MEDTECH CORPORATION | Chairman | 29-08-2023 |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | Chairman | 29-08-2023 |
Vas-Cath, Inc.
Vas-Cath, Inc. Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Vas-Cath, Inc. is a Canadian company that specializes in catheters for hemodialysis. The private company is based in Mississauga, Canada. Vas-Cath was acquired by Bard Canada, Inc. on December 05, 1994. | Director/Board Member | 01-01-1995 |
Opleiding van Qi Yi Luo
Queen's University | Graduate Degree |
Yunnan Technology & Business University | Undergraduate Degree |
University of Shanghai for Science & Technology | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
MICROPORT SCIENTIFIC CORPORATION | Health Technology |
SHANGHAI MICROPORT EP MEDTECH CO., LTD. | Commercial Services |
MICROPORT CARDIOFLOW MEDTECH CORPORATION | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Vas-Cath, Inc.
Vas-Cath, Inc. Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Vas-Cath, Inc. is a Canadian company that specializes in catheters for hemodialysis. The private company is based in Mississauga, Canada. Vas-Cath was acquired by Bard Canada, Inc. on December 05, 1994. | Health Technology |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | Health Technology |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Finance |